IM Cannabis Corp. (CSE:IMCC)

Market Cap	7.00M
Revenue (ttm)	54.47M
Net Income (ttm)	-4.69M
Shares Out	3.09M
EPS (ttm)	-1.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	226
Open	2.270
Previous Close	2.270
Day's Range	2.270 - 2.270
52-Week Range	1.880 - 10.560
Beta	1.91
RSI	51.02
Earnings Date	May 8, 2025

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 95
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IMCC

Financial Performance

In 2024, IM Cannabis's revenue was 54.03 million, an increase of 10.71% compared to the previous year's 48.80 million. Losses were -10.59 million, 11.4% more than in 2023.